Contact

All Stories

  1. Radioiodination of Two Carborane‐Based Dual Cyclooxygenase‐2/5‐Lipoxygenase Inhibitors and Their In Vitro and In Vivo Evaluation

    Article • ChemBioChem, March 2026, Wiley

    Prof. Dr. Jens Pietzsch

  2. Front Cover: Radioiodination of Two Carborane‐Based Dual Cyclooxygenase‐2/5‐Lipoxygenase Inhibitors and Their In Vitro and In Vivo Evaluation (ChemBioChem 7/2026)

    Article • ChemBioChem, March 2026, Wiley

    Prof. Dr. Jens Pietzsch

  3. nido-carborane conjugates with ibuprofen, flurbiprofen and fenoprofen: synthesis, characterization, COX inhibition potential and anticancer activity

    Article • Journal of Inorganic Biochemistry, March 2026, Elsevier

    Prof. Dr. Jens Pietzsch

  4. Smart Delivery: Designing Peptides that Use Cancer Enzymes to Find Their Target

    Article • ACS Pharmacology & Translational Science, February 2026, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  5. Automatic Delineation of Tumor Spheroids in Microscopic Images Using Deep-Learning

    Article • ACS Measurement Science Au, February 2026, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  6. A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutrophil recruitment and immunosuppression

    Article • Biomaterials, January 2026, Elsevier

    Prof. Dr. Jens Pietzsch

  7. In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency

    Article • Pharmaceuticals, November 2025, MDPI AG

    Prof. Dr. Jens Pietzsch

  8. Novel Ruthenacarborane–NSAID Conjugates

    Article • Molecules, October 2025, MDPI AG

    Prof. Dr. Jens Pietzsch

  9. “Precision on Two Wheels”─Structural Refinement of 64 Cu- and 68 Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Prec...

    Article • Journal of Medicinal Chemistry, October 2025, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  10. Investigation of the Putative Relationship Between Copper Transport and the Anticancer Activity of Cisplatin in Ductal Pancreatic Adenocarcinoma

    Article • Cells, September 2025, MDPI AG

    Prof. Dr. Jens Pietzsch

  11. Radioresistant mouse pheochromocytoma cell lines

    Article • Frontiers in Oncology, July 2025, Frontiers

    Prof. Dr. Jens Pietzsch

  12. Exploring the Role of Peripheral Macrophages in Glioma Progression: The Metabolic Significance of Cyclooxygenase-2 (COX-2)

    Article • International Journal of Molecular Sciences, June 2025, MDPI AG

    Prof. Dr. Jens Pietzsch

  13. It’s a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies

    Article • EJNMMI Radiopharmacy and Chemistry, June 2025, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  14. Front Cover: Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index (ChemMedChem 11/2025)

    Article • ChemMedChem, June 2025, Wiley

    Prof. Dr. Jens Pietzsch

  15. Cover Feature: Advances in Diclofenac Derivatives: Exploring Carborane‐Substituted N‐Methyl and Nitrile Analogs for Anticancer Therapy (ChemMedChem 11/2025)

    Article • ChemMedChem, June 2025, Wiley

    Prof. Dr. Jens Pietzsch

  16. Deciphering the Tumor Uptake of Heterobivalent (SST2/Albumin) [64Cu]Cu-NODAGA-cLAB-TATEs

    Article • Journal of Medicinal Chemistry, May 2025, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  17. Development of [99mTc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer

    Article • Journal of Medicinal Chemistry, March 2025, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  18. Carborane‐based Analogues of Celecoxib and Flurbiprofen, their COX Inhibition Potential and COX Selectivity Index

    Article • ChemMedChem, March 2025, Wiley

    Prof. Dr. Jens Pietzsch

  19. Advances in Diclofenac Derivatives: Exploring Carborane‐Substituted N‐Methyl and Nitrile Analogs for Anti‐Cancer Therapy

    Article • ChemMedChem, March 2025, Wiley

    Prof. Dr. Jens Pietzsch

  20. Exploring a Nitric Oxide-Releasing Celecoxib Derivative as a Potential Modulator of Bone Healing: Insights from Ex Vivo and In Vivo Imaging Experiments

    Article • International Journal of Molecular Sciences, March 2025, MDPI AG

    Prof. Dr. Jens Pietzsch

  21. Front Cover: Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity (ChemMedChem 1/2025)

    Article • ChemMedChem, January 2025, Wiley

    Prof. Dr. Jens Pietzsch

  22. Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potential

    Article • Scientific Reports, December 2024, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  23. Towards more reliable experimental models for pancreatic cancer

    Article • Cancers, October 2024, MDPI AG

    Prof. Dr. Jens Pietzsch

  24. Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al18F/68Ga/111In

    Article • Bioconjugate Chemistry, August 2024, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  25. Programmable Release of Chemotherapeutics from Ferrocene‐Based Injectable Hydrogels Slows Melanoma Growth

    Article • Advanced Healthcare Materials, July 2024, Wiley

    Prof. Dr. Jens Pietzsch

  26. Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity

    Article • ChemMedChem, June 2024, Wiley

    Prof. Dr. Jens Pietzsch

  27. Cover Feature: 64Cu tumor labeling with hexadentate picolinic acid‐based bispidine immunoconjugates (Chem. Eur. J. 32/2024)

    Article • Chemistry - A European Journal, May 2024, Wiley

    Prof. Dr. Jens Pietzsch

  28. 64 Cu tumor labeling with hexadentate picolinic acid‐based bispidine immunoconjugates

    Article • Chemistry - A European Journal, March 2024, Wiley

    Prof. Dr. Jens Pietzsch

  29. Impact of Viscosity on Human Hepatoma Spheroids in Soft Core–Shell Microcapsules

    Article • Advanced Healthcare Materials, January 2024, Wiley

    Prof. Dr. Jens Pietzsch

  30. Correction to: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

    Article • European Journal of Pediatrics, January 2024, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  31. Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2

    Article • EJNMMI Radiopharmacy and Chemistry, January 2024, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  32. Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments

    Article • Theranostics, January 2024, Ivyspring International Publisher

    Prof. Dr. Jens Pietzsch

  33. Towards an advanced clinical use of radiocopper in cancer theranostics

    Article • Theranostics, January 2024, Ivyspring International Publisher

    Prof. Dr. Jens Pietzsch

  34. Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma

    Article • European Journal of Pediatrics, November 2023, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  35. Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging

    Article • ChemMedChem, September 2023, Wiley

    Prof. Dr. Jens Pietzsch

  36. Correction to Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies

    Article • ACS Sensors, August 2023, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  37. Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis

    Article • Cells, July 2023, MDPI AG

    Prof. Dr. Jens Pietzsch

  38. Comparative Saturation Binding Analysis of 64Cu-Labeled Somatostatin Analogues Using Cell Homogenates and Intact Cells

    Article • ACS Omega, June 2023, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  39. Synthesis and In Vitro Biological Evaluation of p-Carborane-Based Di-tert-butylphenol Analogs

    Article • Molecules, June 2023, MDPI AG

    Prof. Dr. Jens Pietzsch

  40. Outside Back Cover: (Biotechnology Journal 6/2023)

    Article • Biotechnology Journal, June 2023, Wiley

    Prof. Dr. Jens Pietzsch

  41. Reactivating damaged motor neurons using magnetic fields

    Article • Cells, May 2023, MDPI AG

    Prof. Dr. Jens Pietzsch

  42. Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Prof. Dr. Jens Pietzsch

  43. Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents

    Article • Advanced Therapeutics, May 2023, Wiley

    Prof. Dr. Jens Pietzsch

  44. Carborane‐based Tebufelone Analogs and their Biological Evaluation In Vitro

    Article • ChemMedChem, May 2023, Wiley

    Prof. Dr. Jens Pietzsch

  45. Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells

    Article • Frontiers in Immunology, April 2023, Frontiers

    Prof. Dr. Jens Pietzsch

  46. Metastatic pheochromocytoma and paraganglioma: Somatostatin receptor 2 expression, genetics and therapeutic responses

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2023, Endocrine Society

    Prof. Dr. Jens Pietzsch

  47. Shell engineering in soft alginate‐based capsules for culturing liver spheroids

    Article • Biotechnology Journal, March 2023, Wiley

    Prof. Dr. Jens Pietzsch

  48. Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins

    Article • Journal of Medicinal Chemistry, March 2023, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  49. A self-assembled dynamic extracellular matrix-like hydrogel system with multi-scale structures for cell bioengineering applications

    Article • Acta Biomaterialia, March 2023, Elsevier

    Prof. Dr. Jens Pietzsch

  50. Front Cover: Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity (ChemMedChem 5/2023)

    Article • ChemMedChem, March 2023, Wiley

    Prof. Dr. Jens Pietzsch

  51. Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies

    Article • ACS Sensors, February 2023, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  52. Microdialysis Reveals Anti-Inflammatory Effects of Sulfated Glycosaminoglycanes in the Early Phase of Bone Healing

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Prof. Dr. Jens Pietzsch

  53. Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors

    Article • Molecules, January 2023, MDPI AG

    Prof. Dr. Jens Pietzsch

  54. Prostaglandins and the Lung

    Article • Bioengineering, January 2023, MDPI AG

    Prof. Dr. Jens Pietzsch

  55. The Impact of Nε-Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Prof. Dr. Jens Pietzsch

  56. Modulating the Renal Clearance of Targeted Radiopharmaceuticals

    Article • Journal of Medicinal Chemistry, January 2023, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  57. Carborane-based Compounds in Dual Inhibitor Design

    Article • Advanced Therapeutics, January 2023, Wiley

    Prof. Dr. Jens Pietzsch

  58. Pheochromocytoma radionuclide theranostics and radiation transcriptomics

    Article • Theranostics, January 2023, Ivyspring International Publisher

    Prof. Dr. Jens Pietzsch

  59. Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity

    Article • ChemMedChem, December 2022, Wiley

    Prof. Dr. Jens Pietzsch

  60. Impact of Sulfated Hyaluronan on Bone Metabolism in Diabetic Charcot Neuroarthropathy and Degenerative Arthritis

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Prof. Dr. Jens Pietzsch

  61. Toward Personalized Medicine: One Chelator for Imaging and Therapy with Lutetium-177 and Actinium-225

    Article • Journal of the American Chemical Society, November 2022, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  62. Targeting neuropeptide receptors for cancer imaging

    Article • Cancers, October 2022, MDPI AG

    Prof. Dr. Jens Pietzsch, Professor Dr. Dirk Hellwig

  63. New link between dietary phosphate and coronary heart disease

    Article • Biomedicines, October 2022, MDPI AG

    Prof. Dr. Jens Pietzsch

  64. NO• donors in cancer therapy

    Article • Molecules, October 2022, MDPI AG

    Prof. Dr. Jens Pietzsch

  65. Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome

    Article • Frontiers in Endocrinology, September 2022, Frontiers

    Prof. Dr. Jens Pietzsch

  66. Better understanding the metabolic stability of radiotracers

    Article • Cells, August 2022, MDPI AG

    Prof. Dr. Jens Pietzsch

  67. Shell engineering in soft alginate-based capsules for culturing liver tumoroids

    Article • July 2022, Wiley

    Prof. Dr. Jens Pietzsch

  68. Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation

    Article • ACS Omega, June 2022, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  69. Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates

    Article • International Journal of Molecular Sciences, April 2022, MDPI AG

    Prof. Dr. Jens Pietzsch

  70. The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells

    Article • Cells, April 2022, MDPI AG

    Prof. Dr. Jens Pietzsch

  71. Acceleration to the next level

    Article • Nature Nanotechnology, March 2022, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  72. Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures

    Article • Endocrine Related Cancer, March 2022, Bioscientifica

    Prof. Dr. Jens Pietzsch

  73. CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells

    Article • Cells, February 2022, MDPI AG

    Prof. Dr. Jens Pietzsch

  74. A Self‐Assembled Matrix System for Cell‐Bioengineering Applications in Different Dimensions, Scales, and Geometries

    Article • Small, February 2022, Wiley

    Prof. Dr. Jens Pietzsch

  75. Targeting estrogen receptors in melanoma

    Article • Journal of Investigative Dermatology, January 2022, Elsevier

    Prof. Dr. Jens Pietzsch

  76. Targeting bone with copper radionuclides

    Article • Dalton Transactions, January 2022, Royal Society of Chemistry

    Prof. Dr. Jens Pietzsch, Professor Petr Hermann

  77. “Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals

    Article • Journal of Medicinal Chemistry, December 2021, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  78. Solid-Phase Synthesis of Selectively Mono-Fluorobenz(o)ylated Polyamines as a Basis for the Development of 18F-Labeled Radiotracers

    Article • Molecules, November 2021, MDPI AG

    Prof. Dr. Jens Pietzsch

  79. Hybrid agents for multimodal imaging

    Article • Pharmaceuticals, November 2021, MDPI AG

    Prof. Dr. Jens Pietzsch

  80. Men who stare at bone: multimodal monitoring of bone healing

    Article • Biological Chemistry, July 2021, De Gruyter

    Prof. Dr. Jens Pietzsch

  81. Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics

    Article • ChemMedChem, June 2021, Wiley

    Prof. Dr. Jens Pietzsch

  82. Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue

    Article • Molecules, May 2021, MDPI AG

    Prof. Dr. Jens Pietzsch

  83. Conductive Hydrogels with Dynamic Reversible Networks for Biomedical Applications

    Article • Advanced Healthcare Materials, April 2021, Wiley

    Prof. Dr. Jens Pietzsch

  84. Immunocompatibility and non-thrombogenicity of gelatin-based hydrogels

    Article • Clinical Hemorheology and Microcirculation, April 2021, IOS Press

    Prof. Dr. Jens Pietzsch, Andreas Lendlein

  85. Convergent synthesis of diversified reversible network leads to liquid metal-containing conductive hydrogel adhesives

    Article • Nature Communications, April 2021, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  86. Development of an 18F-Labeled Irreversible Inhibitor of Transglutaminase 2 as Radiometric Tool for Quantitative Expression Profiling in Cells and Tissues

    Article • Journal of Medicinal Chemistry, March 2021, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  87. Development of a ghrelin receptor inverse agonist for positron emission tomography

    Article • Oncotarget, March 2021, Impact Journals, LLC

    Prof. Dr. Jens Pietzsch

  88. The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease

    Article • Hormone and Metabolic Research, March 2021, Thieme Publishing Group

    Prof. Dr. Jens Pietzsch, Manuel Mayr, Professor Fiona M Watt

  89. Response of Endothelial Cells to Gelatin-Based Hydrogels

    Article • ACS Biomaterials Science & Engineering, January 2021, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  90. Pseudohypoxia causes radioresistance

    Article • Cancers, January 2021, MDPI AG

    Prof. Dr. Jens Pietzsch

  91. Screening Arrays of Laminin Peptides on Modified Cellulose for Promotion of Adhesion of Primary Endothelial and Neural Precursor Cells

    Article • Advanced Biology, January 2021, Wiley

    Prof. Dr. Jens Pietzsch

  92. A modular, injectable, non-covalently assembled hydrogel system features widescale tunable degradability for controlled release and tissue integration

    Article • Biomaterials, December 2020, Elsevier

    Prof. Dr. Jens Pietzsch

  93. The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts

    Article • Molecules, November 2020, MDPI AG

    Prof. Dr. Jens Pietzsch

  94. The influence of different artificial extracellular matrix implant coatings on the regeneration of a critical size femur defect in rats

    Article • Materials Science and Engineering C, November 2020, Elsevier

    Prof. Dr. Jens Pietzsch

  95. Pseudohypoxia promotes metastasis

    Article • Endocrine Related Cancer, November 2020, Bioscientifica

    Prof. Dr. Jens Pietzsch

  96. Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging

    Article • Pharmaceuticals, September 2020, MDPI AG

    Prof. Dr. Jens Pietzsch

  97. Radiopharmaceutical Cancer Research goes 3D

    Article • Cancers, September 2020, MDPI AG

    Prof. Dr. Jens Pietzsch

  98. Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas

    Article • The Journal of Pathology, July 2020, Wiley

    Prof. Dr. Jens Pietzsch

  99. Fighting Cancer: Targeting the Eph Receptor Tyrosine Kinase Subfamily

    Article • ACS Omega, June 2020, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  100. Comparison of manual and automated ventricle segmentation in the maternal immune stimulation rat model of schizophrenia

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Prof. Dr. Jens Pietzsch

  101. The sigma-1 receptor: Potential role in the modulation of cellular radiation sensitivity

    Article • Journal of Cellular Biotechnology, May 2020, IOS Press

    Prof. Dr. Jens Pietzsch

  102. Adjuvant Drug-Assisted Bone Healing: Advances and Challenges in Drug Delivery Approaches

    Article • Pharmaceutics, May 2020, MDPI AG

    Prof. Dr. Jens Pietzsch

  103. Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells

    Article • Scientific Reports, March 2020, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  104. Regulation of bone regeneration

    Article • Clinical Hemorheology and Microcirculation, January 2020, IOS Press

    Prof. Dr. Jens Pietzsch

  105. Adjuvant drug-assisted bone healing: Part I – Modulation of inflammation

    Article • Clinical Hemorheology and Microcirculation, January 2020, IOS Press

    Prof. Dr. Jens Pietzsch

  106. Adjuvant drug-assisted bone healing: Part II – Modulation of angiogenesis

    Article • Clinical Hemorheology and Microcirculation, January 2020, IOS Press

    Prof. Dr. Jens Pietzsch

  107. Adjuvant drug-assisted bone healing: Part III – Further strategies for local and systemic modulation

    Article • Clinical Hemorheology and Microcirculation, January 2020, IOS Press

    Prof. Dr. Jens Pietzsch

  108. Synthesis, radiolabelling and initial biological characterisation of 18F-labelled xanthine derivatives for PET imaging of Eph receptors

    Article • Organic & Biomolecular Chemistry, January 2020, Royal Society of Chemistry

    Prof. Dr. Jens Pietzsch

  109. Deuteration versus ethylation – strategies to improve the metabolic fate of an 18F-labeled celecoxib derivative

    Article • RSC Advances, January 2020, Royal Society of Chemistry

    Prof. Dr. Jens Pietzsch

  110. Fluorescent mouse pheochromocytoma spheroids expressing hypoxia-inducible factor 2 alpha: Morphologic and radiopharmacologic characterization

    Article • Journal of Cellular Biotechnology, December 2019, IOS Press

    Prof. Dr. Jens Pietzsch

  111. Active Targeting of Dendritic Polyglycerols for Diagnostic Cancer Imaging

    Article • Small, December 2019, Wiley

    Prof. Dr. Jens Pietzsch

  112. Bone healing made visible

    Article • Clinical Hemorheology and Microcirculation, November 2019, IOS Press

    Prof. Dr. Jens Pietzsch

  113. Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs

    Article • Molecules, October 2019, MDPI AG

    Prof. Dr. Jens Pietzsch

  114. Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician

    Article • Cancers, October 2019, MDPI AG

    Prof. Dr. Jens Pietzsch

  115. Characterization of Tissue Transglutaminase as a Potential Biomarker for Tissue Response toward Biomaterials

    Article • ACS Biomaterials Science & Engineering, October 2019, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  116. A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCAR

    Article • OncoImmunology, September 2019, Taylor & Francis

    Prof. Dr. Jens Pietzsch

  117. Radiochemical and radiopharmacological characterization of a 64 Cu-labeled α-MSH analog conjugated with different chelators

    Article • Journal of Labelled Compounds, June 2019, Wiley

    Prof. Dr. Jens Pietzsch

  118. Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background

    Article • Cancers, May 2019, MDPI AG

    Prof. Dr. Jens Pietzsch

  119. Cytocompatible, Injectable, and Electroconductive Soft Adhesives with Hybrid Covalent/Noncovalent Dynamic Network

    Article • Advanced Science, May 2019, Wiley

    Prof. Dr. Jens Pietzsch

  120. Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC

    Article • EJNMMI Research, May 2019, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  121. Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines

    Article • ACS Omega, May 2019, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  122. Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index

    Article • Journal of Medicinal Chemistry, May 2019, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  123. Synthesis and preliminary radiopharmacological characterisation of an 11 C-labelled azadipeptide nitrile as potential PET tracer for imaging of cysteine cathepsins

    Article • Journal of Labelled Compounds, May 2019, Wiley

    Prof. Dr. Jens Pietzsch

  124. Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells

    Article • Cancers, April 2019, MDPI AG

    Prof. Dr. Jens Pietzsch

  125. Limited importance of EphrinA1–ligand, Src kinase, and focal adhesion kinase in EphA2-mediated regulation of metastasis in Mel-Juso and A375 human melanoma cells

    Article • Journal of Cellular Biotechnology, April 2019, IOS Press

    Prof. Dr. Jens Pietzsch

  126. Regulation of A375 melanoma cell adhesion and migration by EphB4 and EphrinB2 – insights from co-culture experiments

    Article • Journal of Cellular Biotechnology, April 2019, IOS Press

    Prof. Dr. Jens Pietzsch

  127. Cover Feature: Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines (ChemMedChem 3/2019)

    Article • ChemMedChem, February 2019, Wiley

    Prof. Dr. Jens Pietzsch

  128. Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines

    Article • ChemMedChem, January 2019, Wiley

    Prof. Dr. Jens Pietzsch

  129. Fluorine-18 Labeling of S100 Proteins for Small Animal Positron Emission Tomography

    Article • January 2019, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  130. One-Pot Cascade Synthesis of Pyrazole Based Isosteres of Valdecoxib by a [3+2] Cycloaddition Sequence and Evaluation of Their Cox Inhibitory Activity

    Article • Heterocycles, January 2019, Japan Institute of Heterocyclic Chemistry

    Prof. Dr. Jens Pietzsch

  131. Strain-specific metastatic phenotypes in pheochromocytoma allograft mice

    Article • Endocrine Related Cancer, December 2018, Bioscientifica

    Prof. Dr. Jens Pietzsch

  132. Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo

    Article • Oncotarget, October 2018, Impact Journals, LLC

    Prof. Dr. Jens Pietzsch

  133. Synthesis, 18F-labelling and radiopharmacological characterisation of the C-terminal 30mer of Clostridium perfringens enterotoxin as a potential claudin-targeting peptide

    Article • Amino Acids, September 2018, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  134. Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells

    Article • Blood Cancer Journal, August 2018, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch, Paula Videira

  135. Exploring pitfalls of 64Cu-labeled EGFR-targeting peptide GE11 as a potential PET tracer

    Article • Amino Acids, July 2018, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  136. Causative treatment of acid aspiration induced acute lung injury – Recent trends from animal experiments and critical perspective

    Article • Clinical Hemorheology and Microcirculation, May 2018, IOS Press

    Prof. Dr. Jens Pietzsch

  137. From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo

    Article • Oncotarget, May 2018, Impact Journals, LLC

    Prof. Dr. Jens Pietzsch

  138. Evaluation of Fluorine-18-Labeled α1(I)-N-Telopeptide Analogs as Substrate-Based Radiotracers for PET Imaging of Melanoma-Associated Lysyl Oxidase

    Article • Frontiers in Chemistry, April 2018, Frontiers

    Prof. Dr. Jens Pietzsch

  139. Synthesis, Characterization, and Initial Biological Evaluation of [99m Tc]Tc-Tricarbonyl-labeled DPA-α-MSH Peptide Derivatives for Potential Melanoma Imaging

    Article • ChemMedChem, April 2018, Wiley

    Prof. Dr. Jens Pietzsch

  140. Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure–Activity Relationships, and Pharmacokinetic Profiling

    Article • Journal of Medicinal Chemistry, April 2018, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  141. Bridging from Brain to Tumor Imaging: (S)-(−)- and (R)-(+)-[18F]Fluspidine for Investigation of Sigma-1 Receptors in Tumor-Bearing Mice

    Article • Molecules, March 2018, MDPI AG

    Prof. Dr. Jens Pietzsch

  142. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology

    Article • Journal of Autoimmunity, March 2018, Elsevier

    Professor Tjalf Ziemssen, Prof. Dr. Jens Pietzsch

  143. Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments

    Article • Molecules, February 2018, MDPI AG

    Prof. Dr. Jens Pietzsch

  144. Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity

    Article • MedChemComm, January 2018, Royal Society of Chemistry

    Prof. Dr. Jens Pietzsch

  145. Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells

    Article • Oncotarget, December 2017, Impact Journals, LLC

    Prof. Dr. Jens Pietzsch

  146. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment

    Article • BMC Cancer, November 2017, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  147. Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells

    Article • Oncotarget, September 2017, Impact Journals, LLC

    Prof. Dr. Jens Pietzsch

  148. Preparation of a novel radiotracer targeting the EphB4 receptor via radiofluorination using spiro azetidinium salts as precursor

    Article • Journal of Labelled Compounds, August 2017, Wiley

    Prof. Dr. Jens Pietzsch

  149. Biological characterization of novel nitroimidazole-peptide conjugates in vitr o and in vivo

    Article • Journal of Peptide Science, March 2017, Wiley

    Prof. Dr. Jens Pietzsch

  150. Novel Tumor Pretargeting System Based on Complementaryl-Configured Oligonucleotides

    Article • Bioconjugate Chemistry, March 2017, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  151. In Vivo Examination of an Injectable Hydrogel System Crosslinked by Peptide-Oligosaccharide Interaction in Immunocompetent Nude Mice

    Article • Advanced Functional Materials, March 2017, Wiley

    Prof. Dr. Jens Pietzsch

  152. Human Endothelial Cell Models in Biomaterial Research

    Article • Trends in Biotechnology, March 2017, Elsevier

    Prof. Dr. Jens Pietzsch

  153. Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”

    Article • Oncotarget, February 2017, Impact Journals, LLC

    Prof. Dr. Jens Pietzsch

  154. Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy

    Article • Scientific Reports, February 2017, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  155. A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform

    Article • OncoImmunology, February 2017, Taylor & Francis

    Prof. Dr. Jens Pietzsch

  156. Surface charge and particle size determine the metabolic fate of dendritic polyglycerols

    Article • Nanoscale, January 2017, Royal Society of Chemistry

    Prof. Dr. Jens Pietzsch

  157. The why and how of amino acid analytics in cancer diagnostics and therapy

    Article • Journal of Biotechnology, January 2017, Elsevier

    Prof. Dr. Jens Pietzsch

  158. Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection

    Article • Dalton Transactions, January 2017, Royal Society of Chemistry

    Prof. Dr. Jens Pietzsch

  159. Development of a18F-labeled Diaryl-Substituted Dihydropyrrolo[3,2,1-hi]indole as Potential Probe for Functional Imaging of Cyclooxygenase-2 with PET

    Article • ChemistrySelect, November 2016, Wiley

    Prof. Dr. Jens Pietzsch

  160. S100 proteins and scavenger receptors: what's going on?

    Article • Amino Acids, October 2016, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  161. Zwitterionic Polymer-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Low Protein Interaction and High Biocompatibility

    Article • ChemNanoMat, September 2016, Wiley

    Prof. Dr. Jens Pietzsch

  162. Extracellular S100A4 affects endothelial cell integrity and stimulates transmigration of A375 melanoma cells

    Article • Biochemical and Biophysical Research Communications, September 2016, Elsevier

    Prof. Dr. Jens Pietzsch

  163. Corrigendum: Synthesis and Kinetic Characterisation of Water-Soluble Fluorogenic Acyl Donors for Transglutaminase 2

    Article • ChemBioChem, August 2016, Wiley

    Prof. Dr. Jens Pietzsch

  164. Synthesis and Kinetic Characterisation of Water-Soluble Fluorogenic Acyl Donors for Transglutaminase 2

    Article • ChemBioChem, May 2016, Wiley

    Prof. Dr. Jens Pietzsch

  165. Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review

    Article • Antioxidants, April 2016, MDPI AG

    Prof. Dr. Jens Pietzsch

  166. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells

    Article • Journal of Cellular and Molecular Medicine, March 2016, Wiley

    Prof. Dr. Jens Pietzsch

  167. 177Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment

    Article • EJNMMI Research, January 2016, Springer Science + Business Media

    Professor Petr Hermann, Prof. Dr. Jens Pietzsch

  168. Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitro

    Article • Clinical Hemorheology and Microcirculation, January 2016, IOS Press

    Prof. Dr. Jens Pietzsch

  169. Controlled immobilization of His-tagged proteins for protein-ligand interaction experiments using Ni2+-NTA layer on glass surfaces

    Article • Clinical Hemorheology and Microcirculation, January 2016, IOS Press

    Prof. Dr. Jens Pietzsch

  170. Gelatin-based Hydrogel Degradation and Tissue Interactionin vivo: Insights from Multimodal Preclinical Imaging in Immunocompetent Nude Mice

    Article • Theranostics, January 2016, Ivyspring International Publisher

    Andreas Lendlein, Prof. Dr. Jens Pietzsch

  171. Multimodal Somatostatin Receptor Theranostics Using [64Cu]Cu-/[177Lu]Lu-DOTA-(Tyr3)octreotate and AN-238 in a Mouse Pheochromocytoma Model

    Article • Theranostics, January 2016, Ivyspring International Publisher

    Prof. Dr. Jens Pietzsch

  172. Radiopharmacological characterization of 64Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma

    Article • Amino Acids, December 2015, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  173. 68Ga- und 177Lu-markierte Bisphosphonate als Knochenmetastasen-Theranostika

    Article • TumorDiagnostik & Therapie, September 2015, Thieme Publishing Group

    Prof. Dr. Jens Pietzsch, Professor Petr Hermann

  174. Influence of irradiation on release of endothelial microparticles (EMP) in vitro

    Article • Clinical Hemorheology and Microcirculation, September 2015, SAGE Publications

    Prof. Dr. Jens Pietzsch

  175. Development of indazolylpyrimidine derivatives as high-affine EphB4 receptor ligands and potential PET radiotracers

    Article • Bioorganic & Medicinal Chemistry, September 2015, Elsevier

    Prof. Dr. Jens Pietzsch

  176. Novel (pyrazolyl)benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors

    Article • Bioorganic & Medicinal Chemistry Letters, August 2015, Elsevier

    Prof. Dr. Jens Pietzsch

  177. Copper(II) Cyclam Complexes withN-­Propionic Acid Pendant Arms

    Article • European Journal of Inorganic Chemistry, July 2015, Wiley

    Prof. Dr. Jens Pietzsch

  178. Effects of pulmonary acid aspiration on the regional pulmonary blood flow within the first hour after injury: An observational study in rats1

    Article • Clinical Hemorheology and Microcirculation, July 2015, IOS Press

    Prof. Dr. Jens Pietzsch

  179. 18F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ1Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging Agent

    Article • Journal of Medicinal Chemistry, July 2015, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  180. Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes

    Article • Frontiers in Chemistry, June 2015, Frontiers

    Prof. Dr. Jens Pietzsch

  181. Synthesis and Biodistribution Studies of 3 H- and 64 Cu-Labeled Dendritic Polyglycerol and Dendritic Polyglycerol Sulfate

    Article • Bioconjugate Chemistry, May 2015, American Chemical Society (ACS)

    Professor Leone Spiccia, Prof. Dr. Jens Pietzsch

  182. Diaryl-Substituted (Dihydro)pyrrolo[3,2,1-hi]indoles, a Class of Potent COX-2 Inhibitors with Tricyclic Core Structure

    Article • The Journal of Organic Chemistry, May 2015, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  183. Reduced pulmonary blood flow in regions of injury 2 hours after acid aspiration in rats

    Article • BMC Anesthesiology, March 2015, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  184. Optical imaging of COX-2: Studies on an autofluorescent 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitor

    Article • Biochemical and Biophysical Research Communications, February 2015, Elsevier

    Prof. Dr. Jens Pietzsch

  185. Cyclopeptides containing the DEKS motif as conformationally restricted collagen telopeptide analogues: synthesis and conformational analysis

    Article • Organic & Biomolecular Chemistry, January 2015, Royal Society of Chemistry

    Prof. Dr. Jens Pietzsch

  186. Novel indole-based sigma-2 receptor ligands: synthesis, structure–affinity relationship and antiproliferative activity

    Article • MedChemComm, January 2015, Royal Society of Chemistry

    Prof. Dr. Jens Pietzsch

  187. Biocompatibility and inflammatory response in vitro and in vivo to gelatin-based biomaterials with tailorable elastic properties

    Article • Biomaterials, December 2014, Elsevier

    Andreas Lendlein, Prof. Dr. Jens Pietzsch

  188. In Vivo Fluorescence Imaging and Urinary Monoamines as Surrogate Biomarkers of Disease Progression in a Mouse Model of Pheochromocytoma

    Article • Endocrinology, November 2014, Endocrine Society

    Prof. Dr. Jens Pietzsch

  189. Radiofluorination and first radiopharmacological characterization of a SWLAY peptide-based ligand targeting EphA2

    Article • Journal of Labelled Compounds, September 2014, Wiley

    Prof. Dr. Jens Pietzsch

  190. Binding properties of radiolabeled cetuximab conjugates

    Article • Nuclear Medicine and Biology, August 2014, Elsevier

    Professor Leone Spiccia, Prof. Dr. Jens Pietzsch

  191. Bispidine Dioxotetraaza Macrocycles: A New Class of Bispidines for 64Cu PET Imaging

    Article • Inorganic Chemistry, June 2014, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  192. Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy

    Article • Pharmaceuticals, March 2014, MDPI AG

    Prof. Dr. Jens Pietzsch

  193. Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages

    Article • Biochemical and Biophysical Research Communications, March 2014, Elsevier

    Prof. Dr. Jens Pietzsch

  194. ChemInform Abstract: Tissue Transglutaminase: An Emerging Target for Therapy and Imaging

    Article • ChemInform, February 2014, Wiley

    Prof. Dr. Jens Pietzsch

  195. Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential

    Article • Radiotherapy and Oncology, February 2014, Elsevier

    Prof. Dr. Jens Pietzsch

  196. 2,3-Diaryl-substituted indole based COX-2 inhibitors as leads for imaging tracer development

    Article • RSC Advances, January 2014, Royal Society of Chemistry

    Prof. Dr. Jens Pietzsch

  197. Organotypical vascular model for characterization of radioprotective compounds: Studies on antioxidant 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors

    Article • Clinical Hemorheology and Microcirculation, January 2014, IOS Press

    Prof. Dr. Jens Pietzsch

  198. Synthesis and radiopharmacological evaluation of 64Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator

    Article • European Journal of Medicinal Chemistry, December 2013, Elsevier

    Professor Leone Spiccia, Prof. Dr. Jens Pietzsch

  199. Tissue transglutaminase: An emerging target for therapy and imaging

    Article • Bioorganic & Medicinal Chemistry Letters, December 2013, Elsevier

    Prof. Dr. Jens Pietzsch

  200. Pulmonary Blood Flow Increases in Damaged Regions Directly after Acid Aspiration in Rats

    Article • Anesthesiology, October 2013, Wolters Kluwer Health

    Prof. Dr. Jens Pietzsch

  201. Optimization of Pentadentate Bispidines as Bifunctional Chelators for64Cu Positron Emission Tomography (PET)

    Article • Inorganic Chemistry, July 2013, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  202. Synthesis and Radiopharmacological Characterisation of a Fluorine-18-Labelled Azadipeptide Nitrile as a Potential PET Tracer for in vivo Imaging of Cysteine Cathepsins

    Article • ChemMedChem, June 2013, Wiley

    Prof. Dr. Jens Pietzsch

  203. Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update

    Article • Molecules, May 2013, MDPI AG

    Prof. Dr. Jens Pietzsch

  204. Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells

    Article • Molecular and Cellular Endocrinology, May 2013, Elsevier

    Prof. Dr. Jens Pietzsch

  205. An Efficient Bioorthogonal Strategy Using CuAAC Click Chemistry for Radiofluorinations of SNEW Peptides and the Role of Copper Depletion

    Article • ChemMedChem, April 2013, Wiley

    Prof. Dr. Jens Pietzsch

  206. Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro

    Article • Melanoma Research, April 2013, Wolters Kluwer Health

    Prof. Dr. Jens Pietzsch

  207. 2-Carbaborane-3-phenyl-1H-indoles-Synthesis via McMurry Reaction and Cyclooxygenase (COX) Inhibition Activity

    Article • ChemMedChem, January 2013, Wiley

    Prof. Dr. Jens Pietzsch

  208. Copper(ii) chemistry of the functionalized macrocycle cyclam tetrapropionic acid

    Article • Dalton Transactions, January 2013, Royal Society of Chemistry

    Holger Stephan, Prof. Dr. Jens Pietzsch

  209. Visualization of cyclooxygenase-2 using a 2,3-diarylsubstituted indole-based inhibitor and confocal laser induced cryofluorescence microscopy at 20K in melanoma cells in vitro

    Article • Biochemical and Biophysical Research Communications, January 2013, Elsevier

    Prof. Dr. Jens Pietzsch

  210. 18F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells

    Article • Nuclear Medicine and Biology, November 2012, Elsevier

    Prof. Dr. Jens Pietzsch

  211. Protein and non-protein biomarkers in melanoma: a critical update

    Article • Amino Acids, October 2012, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  212. Fluorine-18 Radiolabeling and Radiopharmacological Characterization of a Benzodioxolylpyrimidine-based Radiotracer Targeting the Receptor Tyrosine Kinase EphB4

    Article • ChemMedChem, October 2012, Wiley

    Prof. Dr. Jens Pietzsch

  213. Radiosynthesis of a 18F-labeled 2,3-diarylsubstituted indole via McMurry coupling for functional characterization of cyclooxygenase-2 (COX-2) in vitro and in vivo

    Article • Bioorganic & Medicinal Chemistry, June 2012, Elsevier

    Prof. Dr. Jens Pietzsch

  214. Design, Evaluation, and Comparison of Ghrelin Receptor Agonists and Inverse Agonists as Suitable Radiotracers for PET Imaging

    Article • Bioconjugate Chemistry, March 2012, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  215. Irradiation affects cellular properties and Eph receptor expression in human melanoma cells

    Article • Cell Adhesion & Migration, March 2012, Taylor & Francis

    Prof. Dr. Jens Pietzsch

  216. Site-selective radiolabeling of peptides by 18F-fluorobenzoylation with [18F]SFB in solution and on solid phase: a comparative study

    Article • Amino Acids, February 2012, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  217. Cyclin-Dependent Kinases (Cdk) as Targets for Cancer Therapy and Imaging

    Article • November 2011, IntechOpen

    Prof. Dr. Jens Pietzsch

  218. Specific Targeting of Hypoxic Tumor Tissue with Nitroimidazole-Peptide Conjugates

    Article • ChemMedChem, September 2011, Wiley

    Prof. Dr. Jens Pietzsch

  219. Synthesis of an 18F-labeled cyclin-dependent kinase-2 inhibitor

    Article • Journal of Labelled Compounds, September 2011, Wiley

    Prof. Dr. Jens Pietzsch

  220. Automated radiosynthesis of the thiol-reactive labeling agent N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide ([18F]FBAM)

    Article • Applied Radiation and Isotopes, September 2011, Elsevier

    Prof. Dr. Jens Pietzsch

  221. Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells

    Article • Biochemical and Biophysical Research Communications, September 2011, Elsevier

    Prof. Dr. Jens Pietzsch

  222. Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1

    Article • Bioorganic & Medicinal Chemistry Letters, August 2011, Elsevier

    Prof. Dr. Jens Pietzsch

  223. ChemInform Abstract: Synthesis and Evaluation of 1,5‐Diaryl‐Substituted Tetrazoles (IV) as Novel Selective Cyclooxygenase‐2 (COX‐2) Inhibitors.

    Article • ChemInform, June 2011, Wiley

    Prof. Dr. Jens Pietzsch

  224. A novel tetrabranched neurotensin(8–13) cyclam derivative: Synthesis, 64Cu-labeling and biological evaluation

    Article • Journal of Inorganic Biochemistry, June 2011, Elsevier

    Prof. Dr. Jens Pietzsch

  225. Synthesis, characterization and biological evaluation of [188Re(N)(cys∼)(PNP)]+/0 mixed-ligand complexes as prototypes for the development of 188Re(N)-based target-specific radiopharmaceuticals

    Article • Nuclear Medicine and Biology, April 2011, Elsevier

    Prof. Dr. Jens Pietzsch

  226. Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors

    Article • Bioorganic & Medicinal Chemistry Letters, March 2011, Elsevier

    Prof. Dr. Jens Pietzsch

  227. Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: a potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo?

    Article • Amino Acids, December 2010, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  228. S100 proteins in health and disease

    Article • Amino Acids, December 2010, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  229. Modulation of Adrenal Aldosterone Release by Oxidative Modification of Low-Density Lipoprotein

    Article • American Journal of Hypertension, October 2010, Oxford University Press (OUP)

    Prof. Dr. Jens Pietzsch

  230. S100A2 in cancerogenesis: a friend or a foe?

    Article • Amino Acids, June 2010, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  231. Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging

    Article • Mini-Reviews in Medicinal Chemistry, June 2010, Bentham Science Publishers

    Prof. Dr. Jens Pietzsch

  232. Synthesis of neurotensin(8–13)–phosphopeptide heterodimers via click chemistry

    Article • Bioorganic & Medicinal Chemistry Letters, June 2010, Elsevier

    Prof. Dr. Jens Pietzsch

  233. Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo

    Article • The International Journal of Biochemistry & Cell Biology, May 2010, Elsevier

    Prof. Dr. Jens Pietzsch

  234. Improved multimodality imaging using alginate molding in xenograft tumor models

    Article • Journal of Magnetic Resonance Imaging, March 2010, Wiley

    Prof. Dr. Jens Pietzsch

  235. Effects of posture on regional pulmonary blood flow in rats as measured by PET

    Article • Journal of Applied Physiology, February 2010, American Physiological Society

    Prof. Dr. Jens Pietzsch

  236. Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors

    Article • European Journal of Medicinal Chemistry, February 2010, Elsevier

    Prof. Dr. Jens Pietzsch

  237. Eph receptors and ephrins: bloody players

    Article • Journal of Oncology, January 2010, Hindawi Publishing Corporation

    Prof. Dr. Jens Pietzsch

  238. Influence of irradiation on metabolism and metastatic potential of B16-F10 melanoma cells

    Article • International Journal of Radiation Biology, November 2009, Taylor & Francis

    Prof. Dr. Jens Pietzsch

  239. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging

    Article • Nuclear Medicine and Biology, October 2009, Elsevier

    Prof. Dr. Jens Pietzsch

  240. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging

    Article • Nuclear Medicine and Biology, October 2009, Elsevier

    Prof. Dr. Jens Pietzsch

  241. Radiosynthesis and radiopharmacological evaluation of [N-methyl-11C]Org 34850 as a glucocorticoid receptor (GR)-binding radiotracer

    Article • Applied Radiation and Isotopes, February 2009, Elsevier

    Prof. Dr. Jens Pietzsch

  242. Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives

    Article • Bioorganic & Medicinal Chemistry, February 2009, Elsevier

    Prof. Dr. Jens Pietzsch

  243. Cell Cycle Regulating Kinase Cdk4 as a Potential Target for Tumor Cell Treatment and Tumor Imaging

    Article • Journal of Oncology, January 2009, Hindawi Publishing Corporation

    Prof. Dr. Jens Pietzsch

  244. Erratum

    Article • Forschende Komplementärmedizin / Research in Complementary Medicine, January 2009, Karger Publishers

    Prof. Dr. Jens Pietzsch

  245. Fluorine-18 labeling of phosphopeptides: A potential approach for the evaluation of phosphopeptide metabolism in vivo

    Article • Biopolymers, January 2009, Wiley

    Prof. Dr. Jens Pietzsch

  246. Reduction of Arteriosclerotic Nanoplaque Formation and Size by n-3 Fatty Acids in Patients after Valvular Defect Operation

    Article • Complementary Medicine Research, January 2009, Karger Publishers

    Prof. Dr. Jens Pietzsch

  247. Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study

    Article • Atherosclerosis, November 2008, Elsevier

    Prof. Dr. Jens Pietzsch

  248. Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion

    Article • Journal of Endocrinology, October 2008, Bioscientifica

    Prof. Dr. Jens Pietzsch

  249. Synthesis and evaluation in vitro and in vivo of a 11C-labeled cyclooxygenase-2 (COX-2) inhibitor

    Article • Bioorganic & Medicinal Chemistry, August 2008, Elsevier

    Prof. Dr. Jens Pietzsch

  250. Radiolabeled Glucocorticoids as Molecular Probes for Imaging Brain Glucocorticoid Receptors by Means of Positron Emission Tomography (PET)

    Article • Mini-Reviews in Medicinal Chemistry, June 2008, Bentham Science Publishers

    Prof. Dr. Jens Pietzsch

  251. Synthesis and Application of [18F]FDG-Maleimidehexyloxime ([18F]FDG-MHO): A [18F]FDG-Based Prosthetic Group for the Chemoselective18F-Labeling of Peptides and Proteins†

    Article • Bioconjugate Chemistry, June 2008, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  252. Human S100A12: a novel key player in inflammation?

    Article • Amino Acids, April 2008, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  253. Systematic comparison of two novel, thiol-reactive prosthetic groups for 18F labeling of peptides and proteins with the acylation agent succinimidyl-4-[18F]fluorobenzoate ([18F]SFB)

    Article • Amino Acids, April 2008, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  254. Expression, purification and fluorine-18 radiolabeling of recombinant S100 proteins—potential probes for molecular imaging of receptor for advanced glycation endproducts (RAGE) in vivo

    Article • Protein Expression and Purification, February 2008, Elsevier

    Prof. Dr. Jens Pietzsch

  255. Glycoxidation of Low Density Lipoprotein in Impaired Glucose Tolerance: Implications for the Pathogenesis of Diabetic Vascular Disease

    Article • Vascular Disease Prevention, February 2008, Bentham Science Publishers

    Prof. Dr. Jens Pietzsch

  256. Yttrium-86-labelled human serum albumin microspheres: relation of surface structure with in vivo stability

    Article • Nuclear Medicine and Biology, February 2008, Elsevier

    Prof. Dr. Jens Pietzsch

  257. Modified “4 + 1” Mixed Ligand Technetium-Labeled Fatty Acids for Myocardial Imaging: Evaluation of Myocardial Uptake and Biodistribution

    Article • Bioconjugate Chemistry, January 2008, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  258. L-Type Amino Acid Transporters LAT1 and LAT4 in Cancer: Uptake of 3-O-Methyl-6- 18F-Fluoro-L-Dopa in Human Adenocarcinoma and Squamous Cell Carcinoma In Vitro and In Vivo

    Article • Journal of Nuclear Medicine, December 2007, Society of Nuclear Medicine

    Prof. Dr. Jens Pietzsch

  259. Localized proton magnetic resonance spectroscopy of lipids in adipose tissue at high spatial resolution in mice in vivo

    Article • Journal of Lipid Research, November 2007, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof. Dr. Jens Pietzsch

  260. Factors influencing the formation of small dense low-density lipoprotein particles in dependence on the presence of the metabolic syndrome and on the degree of glucose intolerance

    Article • International Journal of Clinical Practice, October 2007, Wiley

    Prof. Dr. Jens Pietzsch

  261. Experimental hypoxia is a potent stimulus for radiotracer uptake in vitro: Comparison of different tumor cells and primary endothelial cells

    Article • Cancer Letters, August 2007, Elsevier

    Prof. Dr. Jens Pietzsch

  262. Myocardial uptake and biodistribution of newly designed technetium-labelled fatty acid analogues

    Article • Nuclear Medicine Communications, August 2007, Wolters Kluwer Health

    Prof. Dr. Jens Pietzsch

  263. Synthesis and radiopharmacological characterization of [11C]AL-438 as a nonsteroidal ligand for imaging brain glucocorticoid receptors

    Article • Bioorganic & Medicinal Chemistry Letters, July 2007, Elsevier

    Prof. Dr. Jens Pietzsch

  264. Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator–activator receptor γ gene expression in macrophages

    Article • Diabetologia, March 2007, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  265. Labeling of low-density lipoproteins using the 18F-labeled thiol-reactive reagent N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide

    Article • Nuclear Medicine and Biology, January 2007, Elsevier

    Prof. Dr. Jens Pietzsch

  266. Lipid transfer protein activities in subjects with impaired glucose tolerance

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2007, De Gruyter

    Prof. Dr. Jens Pietzsch

  267. Synthesis and Biological Evaluation of a New Type of99mTechnetium-Labeled Fatty Acid for Myocardial Metabolism Imaging

    Article • Bioconjugate Chemistry, January 2007, American Chemical Society (ACS)

    Prof. Dr. Jens Pietzsch

  268. Biodistribution and catabolism of 18F-labeled N-ε-fructoselysine as a model of Amadori products

    Article • Nuclear Medicine and Biology, October 2006, Elsevier

    Prof. Dr. Jens Pietzsch

  269. Positron emission tomography in food sciences

    Article • Amino Acids, December 2005, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  270. Glucose-Induced Enhancement of Hemin-Catalyzed LDL Oxidation In Vitro and In Vivo

    Article • Antioxidants & Redox Signaling, November 2005, Mary Ann Liebert Inc

    Prof. Dr. Jens Pietzsch

  271. Small animal positron emission tomography in food sciences

    Article • Amino Acids, September 2005, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  272. Catabolism of native and oxidized low density lipoproteins: in vivo insights from small animal positron emission tomography studies

    Article • Amino Acids, July 2005, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  273. Synthesis and biodistribution of an 18F-labelled resveratrol derivative for small animal positron emission tomography

    Article • Amino Acids, July 2005, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  274. Biodistribution and catabolism of 18F-labelled isopeptide Nɛ-(γ-glutamyl)-L-lysine

    Article • Amino Acids, May 2005, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  275. Fluorine-18 radiolabeling of low-density lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo

    Article • Nuclear Medicine and Biology, November 2004, Elsevier

    Prof. Dr. Jens Pietzsch

  276. Oxidativ modifizierte Lipoproteine und deren Antik�rper bei Patienten mit Antiphospholipidsyndrom und Systemischem Lupus erythematodes

    Article • Zeitschrift für Rheumatologie, August 2004, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  277. The pivotal role of scavenger receptor CD36 and phagocyte-derived oxidants in oxidized low density lipoprotein-induced adhesion to endothelial cells

    Article • The International Journal of Biochemistry & Cell Biology, March 2004, Elsevier

    Prof. Dr. Jens Pietzsch

  278. The protective effects of HDL and its constitutents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL

    Article • Molecular and Cellular Biochemistry, March 2004, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  279. The effect of garlic on arteriosclerotic nanoplaque formation and size

    Article • Phytomedicine, January 2004, Elsevier

    Prof. Dr. Jens Pietzsch

  280. Analysis of non-protein amino acids as specific markers of low density lipoprotein apolipoprotein B-100 oxidation in human atherosclerotic lesions: the use ofN(O)-ethoxycarbonyl trifluoroethyl ester derivatives and GC-MS1

    Article • Spectroscopy An International Journal, January 2004, Hindawi Publishing Corporation

    Prof. Dr. Jens Pietzsch

  281. Analysis of 6-hydroxy-2-aminocaproic acid (HACA) as a specific marker of protein oxidation: The use of N(O,S)-ethoxycarbonyl trifluoroethyl ester derivatives and gas chromatography/mass spectrometry

    Article • Amino Acids, August 2003, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  282. Measurement of 5-hydroxy-2-aminovaleric acid as a specific marker of metal catalysed oxidation of proline and arginine residues of low density lipoprotein apolipoprotein B-100 in human atherosclerotic lesions

    Article • Journal of Clinical Pathology, August 2003, BMJ

    Prof. Dr. Jens Pietzsch

  283. Lack of Association between Serum Paraoxonase 1 Activities and Increased Oxidized Low-Density Lipoprotein Levels in Impaired Glucose Tolerance and Newly Diagnosed Diabetes Mellitus

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2003, Endocrine Society

    Prof. Dr. Jens Pietzsch

  284. Analysis of 3-chlorotyrosine as a specific marker of protein oxidation: the use ofN(O,S)-ethoxycarbonyltrifluoroethyl ester derivatives and gas chromatography/mass spectrometry

    Article • Rapid Communications in Mass Spectrometry, January 2003, Wiley

    Prof. Dr. Jens Pietzsch

  285. Validation of different chemilumigenic substrates for detecting extracellular generation of reactive oxygen species by phagocytes and endothelial cells

    Article • Luminescence, January 2003, Wiley

    Prof. Dr. Jens Pietzsch

  286. In Vivo Evidence for Increased Oxidation of Circulating LDL in Impaired Glucose Tolerance

    Article • Diabetes, October 2002, American Diabetes Association

    Prof. Dr. Jens Pietzsch

  287. Protective Effects of Native But Not Oxidized High-Density Lipoprotein against Proinflammatory Respiratory Burst Activities of Polymorphonuclear Leukocytes Induced by Hypochlorite-Oxidized Low-Density Lipoprotein

    Article • December 2001, Taylor & Francis

    Prof. Dr. Jens Pietzsch

  288. UVB-Induced Conversion of 7-Dehydrocholesterol to 1α,25-Dihydroxyvitamin D3 in an In Vitro Human Skin Equivalent Model

    Article • Journal of Investigative Dermatology, November 2001, Elsevier

    Prof. Dr. Jens Pietzsch

  289. Homocysteine levels in patients treated with lipid apheresis: effect of a vitamin therapy

    Article • European Journal of Clinical Investigation, August 2001, Wiley

    Prof. Dr. Jens Pietzsch

  290. Different susceptibility to oxidation of proline and arginine residues of apolipoprotein B-100 among subspecies of low density lipoproteins

    Article • FEBS Letters, February 2001, Wiley

    Prof. Dr. Jens Pietzsch

  291. Oxidation of Apolipoprotein B-100 in Circulating LDL Is Related to LDL Residence Time

    Article • Arteriosclerosis Thrombosis and Vascular Biology, October 2000, Wolters Kluwer Health

    Prof. Dr. Jens Pietzsch

  292. Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism

    Article • Amino Acids, May 2000, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  293. Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents

    Article • Experimental Dermatology, April 2000, Wiley

    Prof. Dr. Jens Pietzsch

  294. Measurement of 5-Hydroxy-2-aminovaleric Acid as a Specific Marker of Iron-Mediated Oxidation of Proline and Arginine Side-Chain Residues of Low-Density Lipoprotein Apolipoprotein B-100

    Article • Biochemical and Biophysical Research Communications, April 2000, Elsevier

    Prof. Dr. Jens Pietzsch

  295. Urate modifies lipoprotein oxidation

    Article • Molecular and Cellular Biochemistry, January 2000, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  296. Human secretory group IIA phospholipase A2 is associated with lipid metabolism

    Article • Inflammation, January 2000, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  297. Störungen des Lipid- und Lipoproteinstoffwechsels

    Article • January 2000, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch

  298. Metabolic Basis of Low High Density Lipoprotein in Subjects with Impaired Glucose Tolerance

    Article • Annals of the New York Academy of Sciences, November 1999, Wiley

    Prof. Dr. Jens Pietzsch

  299. Very Low Density Lipoprotein Overproduction Is Maximally Expressed in Early Insulin Resistant States

    Article • Annals of the New York Academy of Sciences, November 1999, Wiley

    Prof. Dr. Jens Pietzsch

  300. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance

    Article • Diabetes, December 1998, American Diabetes Association

    Prof. Dr. Jens Pietzsch

  301. Human keratinocyte line HaCaT metabolizes 1α-hydroxyvitamin D3 and vitamin D3 to 1α,25-dihydroxyvitamin D3 (calcitriol)

    Article • Journal of Dermatological Science, November 1998, Elsevier

    Prof. Dr. Jens Pietzsch

  302. Determination of Total Homocysteine

    Article • Clinical Chemistry, August 1998, Oxford University Press (OUP)

    Prof. Dr. Jens Pietzsch

  303. Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells

    Article • Atherosclerosis, February 1998, Elsevier

    Prof. Dr. Jens Pietzsch

  304. Stable isotope ratio analysis of amino acids: the use ofN(O,S)-ethoxycarbonyl trifluoroethyl ester derivatives and gas chromatography/mass spectrometry

    Article • Rapid Communications in Mass Spectrometry, November 1997, Wiley

    Prof. Dr. Jens Pietzsch

  305. Stable isotope ratio analysis of amino acids: the use of N(O,S)-ethoxycarbonyl trifluoroethyl ester derivatives and gas chromatography/mass spectrometry

    Article • Rapid Communications in Mass Spectrometry, November 1997, Wiley

    Prof. Dr. Jens Pietzsch

  306. Rapid Determination of Total Homocysteine in Human Plasma by Using N(O,S)-Ethoxycarbonyl Ethyl Ester Derivatives and Gas Chromatography–Mass Spectrometry,

    Article • Clinical Chemistry, October 1997, Oxford University Press (OUP)

    Prof. Dr. Jens Pietzsch

  307. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition

    Article • Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, January 1995, Elsevier

    Prof. Dr. Jens Pietzsch

  308. Recovery of Cholesterol and Triacylglycerol in Very-Fast Ultracentrifugation of Human Lipoproteins in a Large Range of Concentrations

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 1994, De Gruyter

    Prof. Dr. Jens Pietzsch

  309. Very-fast ultracentrifugation of human plasma lipoproteins: influence of the centrifugal field on lipoprotein composition

    Article • Clinica Chimica Acta, January 1994, Elsevier

    Prof. Dr. Jens Pietzsch